D. Elliot Parks
President & Co-Founder
Dr. Elliot Parks brings over thirty years in biomedical research, product development, executive management, and international venture capital experience to the company. During that time he has had extensive experience in successfully and repeatedly translating important basic research science into commercial products. He was the founding CEO of Myelos Neurosciences a venture-backed, clinical stage biologics company sold to Savient, a NASDAQ listed firm. Prior to Myelos, Dr. Parks was the Director of the Johnson & Johnson Biotechnology Center for ten years, where he was responsible for guiding several biomedical products through clinical trials and regulatory approval. Following receipt of his Ph.D. in Microbiology and Immunology at the University of Washington in Seattle, Dr. Parks assumed research and leadership positions at the Scripps Research Institute during his twelve year tenure there. He also served under the Surgeon General of the Army at Letterman Army Institute of Research in the Presidio in San Francisco.